Recurrent macrophage activation syndrome in spondyloarthritis and monoallelic missense mutations in PRF1: A description of one paediatric case

Clinical and Experimental Rheumatology

Volumn 34, Issue 4, 2016, Pages 719-719

  Filocamo, Giovanni ^a   Petaccia, A ^a   Torcoletti, M ^a   Sieni, E ^b   Ravelli, A ^c   Corona, F ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTIBIOTIC AGENT; CYCLOSPORIN; DEXAMETHASONE; HLA B27 ANTIGEN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PERFORIN; PREDNISONE; IMMUNOSUPPRESSIVE AGENT; PRF1 PROTEIN, HUMAN;

ADOLESCENT; ARTHRALGIA; CASE REPORT; CHILD; DRUG WITHDRAWAL; DYSURIA; FEMALE; FEVER; HEPATOSPLENOMEGALY; HETEROZYGOSITY; HUMAN; HYPERFERRITINEMIA; HYPERTRANSAMINASEMIA; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; HYPONATREMIA; LETTER; MACROPHAGE ACTIVATION SYNDROME; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRF1 GENE; PRIORITY JOURNAL; RASH; REMISSION; SACROILIITIS; SCHOOL CHILD; SPONDYLARTHRITIS; THROMBOCYTE COUNT; URINARY TRACT INFECTION; URTICARIA; UVEITIS; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGE ACTIVATION SYNDROME; MAGNETIC RESONANCE IMAGING; MUTATION, MISSENSE; PERFORIN; PHENOTYPE; RECURRENCE; SPONDYLARTHRITIS; TREATMENT OUTCOME;

EID: 84984815968     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. RAVELLI A, GROM AA, BEHRENS EM, CRON RQ: Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012; 13: 289-98.
2. RAVELLI A, MAGNI-MANZONI S, PISTORIO A et al.: Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604.
3. PETTY RE, SOUTHWOOD TR, MANNERS P et al.; International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
4. MARCENARO S, GALLO F, MARTINI S et al.: Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006; 108: 2316-23.
5. CANNA SW, de JESUS AA, GOUNI S et al.: An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 2014; 46: 1140-6.
6. SCHULERT GS, GROM AA: Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies. Annu Rev Med 2015; 66:145-59.
7. VASTERT SJ, van WIJK R, D'URBANO LE et al.: Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49: 441-9.
8. KAUFMAN KM, LINGHU B, SZUSTAKOWSKI JD et al.: Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol 2014; 66: 3486-95.
9. CANNELLA S, SANTORO A, BRUNO G et al.: Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma. Cancer 2007; 109: 2566-71.
10. RUDWALEIT M, van der HEIJDE D, LANDEWé R et al.: The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70: 25-31.